Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life Genomics is a Swedish genetic testing and clinical laboratory company focused on reproductive and molecular diagnostics. Founded in 2014 in Gothenburg as a spin-off from TATAA Biocenter, the company provides genetic testing services to private clinics and public healthcare providers. Its best-known commercial offerings include non-invasive prenatal testing (NIPT), where it positions itself as Sweden’s only private accredited NIPT laboratory, and distribution of the Ziwig Endotest for endometriosis diagnostics. In September 2025, Life Genomics was acquired by GenePlanet, which kept the Gothenburg laboratory operational as part of its Nordic expansion. The company appears to operate as a commercial diagnostics provider rather than a therapeutics developer, with no disclosed drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LifeGenomix.